News, information and ultimate time of the new provinces of Castile and León Sanidad approves this year as its precision medicine strategy, the ‘middle ground’ for rare, oncological and hereditary numbers

Pasar de la ‘talla única’ al ‘traje a medida‘. It’s the goal that will pursue the new Strategic Medicine Personalized Precision Plan that is underway Sanitation Council and that there is a change in the prevention and treatment of numbers of patients that are distinguished by their genetics, their susceptibility to suffering from a pathology or by their response to a determined treatment.

La strategy, as it is being worked on for the light of this year 2021 and implanting in a progressive manner, will affect both patients who have rare infertile diseases, such as oncological processes and other hereditary basic diseases, explains Ical fuent Consejer Health.

The planicación is based on a new vision of medicine, a paradigm shift that translates into a more accurate clinical approach, both in diagnostics as in treatment, it adjusts to a single patient, which will return in the best of quality, decrease the adverse effects and advance in safety.

With these preconditions, and the “vertical advancement of technology” maneuver, the plan will include 13 strategic lines that include the development of the service map and resource map; parameters to ensure the compliment of the estates; implement technology for the diagnosis of genetic base diseases, while incorporating new specialties into the system such as Genetics Clinic or Bioinformatics.

Objectives

Objectives also pass by the compliment of ethical standards, information maneuver on a large scale; study of the variability of the response to pharmacies, and aspects related to the cooperation, the coordination of professionals and the training.

The document will be included in the investigation, which will also be compared with a plan related to the incorporation of new specialists, including training strategies, such as university, as well as research and innovation tools in the field of diagnostics as well as therapy, big data management and a Pharmacogenetics application.

«The personalized medicine of precision centers the attention to the individual characteristics of the patient. Aunar las ventajas de la technology with the personalization of the assistance allows to center the sanitary attention and adapt in each case », explains to Ical the person in charge of the Regional Reference Unit of Rare Castile and León, DiERCyL, María Isidoro García, which is also the service of the Clinical Analysis Service of the University of Salamanca Assistant Hospital.

Reference model

The doctor addresses the opportunities that patients have over the strategy, based on the «New vision unveiled in Castile and Leon in the long run of the last years, which has been a pioneer in many camps of the genome of Pharmacology or Pharmacogenetics, ”he said.

From hecho, explain, that the Informe del Instituto Roche ‘Personalized medicine in Spain: map of communities‘de 2019, situated in Castilla y León between the communes with mayor desarrollo, together with Andalucía, Cataluña, Galicia and El País Vasco, concluding that «the methodology defined for the application of personalized medicine in Castilla y León is considered a reference level at the state level with potential for implantation in other autonomous communities ». Professional professionals from all over Spain have joined the Community to announce their model, which has more than thirty years of list of aspirations.

Opportunities

What is being done is that the system is moving towards the patient, in such a way that it also facilitates the continuity of assistance, reduces the number of appointments between the distant consultations and the times of response, adjusts the clinical diagnostic resources and the laboratories to the nec of each case, avoid duplicates and facilitates the creation of multidisciplinary teams with a mayor coordination and communication between specialists in the clinical evaluation of patients, adds Isidoro García.

The planning is part of the premise of the extension and geographical dispersion of Castilla y León so that you have coordinated speeches and approve the resources as much as possible. Also, given the difficulties that plant the enormous technological-genomic development and massive sequencing, determination of biomarkers, use of large volumes of data, among others – that obliges Sacyl to incorporate the ultimate advances. Hecho, shows the need for a specialized lift by professionals, both in clinical practice as in the laboratory.

First steps

In these moments, Castilla y León has a variety of plans and services to build the new strategy and amplify it. It is the case of the hereditary cancer program, especially in breast, ovarian and colon cancer; la CSUR National Family Cardiopatías National Reference Unit, in Salamanca, which has a high level of specialized specialization, among other aspects, in the prevention of suicide death; and the Regional Unit for Regional Diagnostic Advancement of Rare Nurses, which currently has 2,500 patients from all over the Community, with the identification of more than 50 ultra-rare patients.

Also, there is the Prenatal Diagnosis Unit Invasive, recently accredited, and the Unit of Pharmacogenetics and Precision Medicine, in Salamanca, pioneered the application of pharmacogenetic studies in the treatment of polymedical patients; the use of biomarkers for the selection of treatment for tumor determination; and the development of therapies CART-t developed in the hospital charro ante some hematologic cancers.

These are the ultimate therapies that demonstrate the characteristics and realities of precision medicine. If human cells – linocytes T – are extracted from the proprietary patient that is genetically modified, administers new to the patient and allows these linocytes T to recognize a specific protein, an antigen, from the tumor cells.

“The strategy of planting new scenarios related to assistance coordination, which can facilitate the access of our patients to the distant assistance structures as well as the implementation of units that can have more need to develop, Garica recalls the of Precision, which will take place in the Senate in 2019 and on which national planning will be maintained. «The autonomous strategy takes into account all the aspects of these conclusions and our position in order to be able to develop each of the aspects, by which we will be completely aligned», Sentencia.

.Source